| HIMS_18421c70 | in the next couple of weeks | 2026-11-10 | 2026-11-24 | FDA provides perspective on explicit rule-making for peptides, specifically TB-500 and BPC-157, following the comment period. | Regulatory clarity is essential for Hims & Hers to launch these specific peptides, which could significantly expand their peptide offering and market opportunity, aligning with the broader GLP-1 theme. | Theme | 2026-11-09 | earnings_transcript | HIMS (ticker) |
| HIMS_7869cc52 | later this month | 2026-11-01 | 2026-11-30 | Hims & Hers launches its Peptides+ offering, including sermorelin, glutathione, and NAD+, with clinician-led treatment plans and access to regular blood testing. | This expands the platform into a new, complex care category, leveraging their infrastructure and potentially driving new revenue streams and customer engagement in the longevity and wellness space. | Ticker | 2026-11-09 | earnings_transcript | HIMS (ticker) |
| HIMS_d8f2182b | ahead of the new year | 2026-10-01 | 2026-12-31 | Hims & Hers will launch flexible multi-month subscriptions across its weight loss assortment and expand access to Lilly's GLP-1 medications, Zepbound and Foundayo. | This broadens treatment options and improves pricing flexibility, potentially increasing customer acquisition, retention, and market share in the high-growth metabolic health category. | Ticker | 2026-11-09 | earnings_transcript | HIMS (ticker) |
| HIMS_aa060124 | before the end of the year | 2026-10-01 | 2026-12-31 | Hims & Hers anticipates its AI-native experience will reach nearly 100% of weight loss subscribers. | This is expected to drive higher engagement, better adherence, and improved customer satisfaction, leading to stronger retention and potentially lower churn. | Ticker | 2026-11-09 | earnings_transcript | HIMS (ticker) |
| AMZN_c962c6d7 | this year | 2026-10-01 | 2026-12-31 | Initial service launch of Amazon Leo (Project Kuiper). | This marks the commercialization of Amazon's satellite internet service, a new revenue stream and a significant investment area, impacting future revenue and free cash flow. | Ticker | 2026-10-29 | earnings_transcript | AMZN (ticker) |
| AMZN_349295e9 | Later in 2026 | 2026-10-01 | 2026-12-31 | Shift in accounting for Amazon LEO costs, such as satellite manufacturing and launch services, from expensing to capitalization. | This accounting change will impact Amazon's reported financial results, potentially improving operating income and free cash flow metrics as significant LEO costs are no longer expensed immediately. | Ticker | 2026-07-30 | earnings_transcript | AMZN (ticker) |
| AMZN_3e5a0b8b | more than 20 launches planned in 2026 | 2026-01-01 | 2026-12-31 | Over 20 Amazon LEO satellite launches in 2026. | These launches represent significant capital expenditures and ongoing operational costs, impacting operating income and cash flow, particularly in the North America segment. The success of these launches is critical for the LEO service. | Ticker | 2026-02-05 | earnings_transcript | AMZN (ticker) |
| AMZN_2c1be643 | expect to invest about $200 billion in capital expenditures across Amazon.com, Inc., but predominantly in AWS | 2026-01-01 | 2028-12-31 | Approximately $200 billion in capital expenditures, primarily in AWS, to meet high demand for core and AI workloads. | These investments are crucial for expanding AWS capacity and maintaining its leadership in cloud and AI, but will impact free cash flow and depreciation, while management expects strong return on invested capital. | Ticker | 2026-02-05 | earnings_transcript | AMZN (ticker) |
| AMZN_61fe0045 | Q1 of next year | 2027-01-01 | 2027-03-31 | Beginning capitalization of Amazon Leo production and launch costs. | This indicates a shift from expensing to capitalizing costs, which can impact reported profitability and free cash flow metrics, signifying the transition of Leo into a more operational phase. | Ticker | 2026-10-29 | earnings_transcript | AMZN (ticker) |
| AMZN_11192811 | more than 30 in 2027 | 2027-01-01 | 2027-12-31 | Over 30 Amazon LEO satellite launches in 2027. | These launches represent significant capital expenditures and ongoing operational costs, impacting operating income and cash flow, particularly in the North America segment. The success of these launches is critical for the LEO service. | Ticker | 2026-02-05 | earnings_transcript | AMZN (ticker) |
| AMZN_7651dd2b | coming in 2027 | 2027-01-01 | 2027-12-31 | Launch and strong interest in Trainium four chips. | This indicates continued innovation and demand for AWS's custom AI chips, reinforcing its competitive position in the AI infrastructure market and potentially driving future AWS revenue growth. | Ticker | 2026-02-05 | earnings_transcript | AMZN (ticker) |
| HIMS_8ce0db05 | within 12 to 18 months | 2027-02-23 | 2027-08-23 | Management target for the collective international business (inclusive of Eucalyptus) to reach break-even on an adjusted EBITDA basis within 12–18 months. | Achievement would validate international scaling playbook, reduce consolidated margin drag and accelerate path to 2030 EBITDA targets; failure to reach break-even would prolong international margin pressure and may require additional investment or slower expansion. | Ticker | 2026-02-23 | earnings_transcript | HIMS (ticker) |